Sequent Scientific Sustainability Profile
Sequent Scientific Ltd., headquartered in India, is a prominent player in the pharmaceutical and biotechnology sectors. Founded in 2006, the company has established itself as a leader in the development and manufacturing of complex generics, particularly in the areas of injectable and oral dosage forms. With a strong operational presence across various regions, Sequent Scientific has achieved significant milestones, including multiple regulatory approvals from global health authorities. The company’s core offerings include a diverse range of pharmaceutical products, with a unique focus on high-quality, cost-effective solutions that cater to the evolving needs of healthcare providers. Sequent Scientific is recognised for its commitment to innovation and quality, positioning itself as a trusted partner in the global pharmaceutical landscape. Its notable achievements underscore its dedication to advancing healthcare through reliable and accessible medicines.
DitchCarbon Score
How does Sequent Scientific's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sequent Scientific's score of 24 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sequent Scientific's reported carbon emissions
In 2024, Sequent Scientific reported total carbon emissions of approximately 20,173,870 kg CO2e for Scope 1 and about 16,394,130 kg CO2e for Scope 2. This marks a significant increase from 2023, where emissions were approximately 17,359,720 kg CO2e for Scope 1 and about 13,459,920 kg CO2e for Scope 2. In India, the 2023 emissions were approximately 9,464,300 kg CO2e for Scope 1 and about 15,137,920 kg CO2e for Scope 2. Sequent Scientific has set ambitious reduction targets, aiming for a 30% decrease in both Scope 1 and Scope 2 emissions by 2030, using a 2021 baseline. This commitment reflects the company's proactive approach to climate action and aligns with industry standards for sustainability. The emissions data is cascaded from Sequent Scientific Limited, indicating a corporate family relationship. The company has not disclosed any Scope 3 emissions data, which typically includes indirect emissions from the supply chain and product use. Overall, Sequent Scientific is taking significant steps towards reducing its carbon footprint and addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 7,125,210 | 00,000,000 | 00,000,000 |
| Scope 2 | 16,552,140 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Sequent Scientific's Industry?
How Carbon Intensive is Sequent Scientific's Location?
Sequent Scientific's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sequent Scientific has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
